A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
Clinical trial NCT01424813 · COMPLETED
Trial details
- NCT number
- NCT01424813
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.